ATE404554T1 - Pyrimidinderivate zur verwendung als antikrebsmittel - Google Patents

Pyrimidinderivate zur verwendung als antikrebsmittel

Info

Publication number
ATE404554T1
ATE404554T1 AT06726601T AT06726601T ATE404554T1 AT E404554 T1 ATE404554 T1 AT E404554T1 AT 06726601 T AT06726601 T AT 06726601T AT 06726601 T AT06726601 T AT 06726601T AT E404554 T1 ATE404554 T1 AT E404554T1
Authority
AT
Austria
Prior art keywords
anticancer agents
pyrimidine derivatives
substituents
man
text
Prior art date
Application number
AT06726601T
Other languages
English (en)
Inventor
Andrew Peter Thomas
Thorsten Nowak
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0506883A external-priority patent/GB0506883D0/en
Priority claimed from GB0525953A external-priority patent/GB0525953D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE404554T1 publication Critical patent/ATE404554T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06726601T 2005-04-05 2006-03-31 Pyrimidinderivate zur verwendung als antikrebsmittel ATE404554T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0506883A GB0506883D0 (en) 2005-04-05 2005-04-05 Chemical compounds
GB0525953A GB0525953D0 (en) 2005-12-21 2005-12-21 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE404554T1 true ATE404554T1 (de) 2008-08-15

Family

ID=36641343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06726601T ATE404554T1 (de) 2005-04-05 2006-03-31 Pyrimidinderivate zur verwendung als antikrebsmittel

Country Status (18)

Country Link
US (1) US20080167297A1 (de)
EP (1) EP1869032B8 (de)
JP (1) JP2008534662A (de)
KR (1) KR20070116994A (de)
AT (1) ATE404554T1 (de)
AU (1) AU2006231116A1 (de)
BR (1) BRPI0609965A2 (de)
CA (1) CA2602372A1 (de)
DE (1) DE602006002271D1 (de)
DK (1) DK1869032T3 (de)
ES (1) ES2310406T3 (de)
HR (1) HRP20080505T3 (de)
IL (1) IL186034A0 (de)
MX (1) MX2007012345A (de)
NO (1) NO20074869L (de)
PT (1) PT1869032E (de)
SI (1) SI1869032T1 (de)
WO (1) WO2006106307A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110131302A (ko) * 2009-03-23 2011-12-06 엠에스디 가부시키가이샤 오로라 ａ 선택적 억제 작용을 갖는 신규한 아미노피리딘 유도체
JP2012521426A (ja) * 2009-03-24 2012-09-13 Ｍｓｄ株式会社 オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
US20110053916A1 (en) * 2009-08-14 2011-03-03 Vertex Pharmaceuticals Incorporated Pyrimidine compounds as tuberculosis inhibitors
BR112014004310B8 (pt) * 2011-08-25 2023-04-18 Merck Sharp & Dohme Composto de pirimidina inibidor da enzima fosfodiesterase 10, composição farmacêutica, uso de um composto
JP2025507682A (ja) * 2022-02-25 2025-03-21 ナロ・セラピューティクス Ｍｙｃファミリー癌原遺伝子タンパク質のモジュレーター
WO2023163712A1 (en) * 2022-02-25 2023-08-31 Nalo Therapeutics Modulators of myc family proto-oncogene protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2426180A1 (de) * 1974-05-29 1975-12-18 Bayer Ag Verfahren zum faerben von polyurethankunststoffen
WO2002022605A1 (en) * 2000-09-15 2002-03-21 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6989385B2 (en) * 2000-12-21 2006-01-24 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6939874B2 (en) * 2001-08-22 2005-09-06 Amgen Inc. Substituted pyrimidinyl derivatives and methods of use
EA013811B1 (ru) * 2002-11-21 2010-08-30 Новартис Вэксинес Энд Дайэгностикс, Инк. 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
CA2542522A1 (en) * 2003-10-17 2005-05-06 Astrazeneca Ab 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer

Also Published As

Publication number Publication date
NO20074869L (no) 2007-11-02
AU2006231116A1 (en) 2006-10-12
CA2602372A1 (en) 2006-10-12
JP2008534662A (ja) 2008-08-28
US20080167297A1 (en) 2008-07-10
ES2310406T3 (es) 2009-01-01
HRP20080505T3 (hr) 2008-11-30
WO2006106307A1 (en) 2006-10-12
EP1869032B8 (de) 2009-03-25
EP1869032A1 (de) 2007-12-26
DK1869032T3 (da) 2008-11-10
KR20070116994A (ko) 2007-12-11
PT1869032E (pt) 2008-10-21
DE602006002271D1 (de) 2008-09-25
IL186034A0 (en) 2008-02-09
MX2007012345A (es) 2007-11-23
BRPI0609965A2 (pt) 2011-10-11
EP1869032B1 (de) 2008-08-13
SI1869032T1 (sl) 2008-12-31
HK1114387A1 (en) 2008-10-31

Similar Documents

Publication Publication Date Title
MX2009009774A (es) Derivados de quinolina como fungicidas.
TN2010000102A1 (en) Novel fungicides
TW200637853A (en) Fungicides
MX2010002243A (es) Derivados fungicidas de 2-alquiltio-2-quinoliniloxi-acetamida.
NO20054856D0 (no) 4-anilo-kinazolinderivater som antiproliferative midler
TW200800956A (en) 2-Aminopyrimidine derivatives
TW200734303A (en) Organic compounds
ATE544760T1 (de) Heterocyclische hydrazidverbindung und ihre verwendung als pestizid
TN2010000064A1 (en) Novel herbicides
MX2010001364A (es) Derivados de ciclopentandiona puenteados triciclicos como herbicidas.
TW200637837A (en) Fungicides
GB0412769D0 (en) Organic compounds
UA101963C2 (en) 4-amino-pyrimidine derivatives
TW200728277A (en) Bicyclic derivatives as P38 inhibitors
MX2007000392A (es) Derivados de 2-pirrolidona sustituida como fungicidas e insecticidas.
GB0508318D0 (en) Organic compounds
IL186034A0 (en) Pyrimidine derivatives for use as anticancer agents
NO20081207L (no) Isoquinolines as IGF-1R inhibitors
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
GB0508314D0 (en) Organic compounds
TW200613251A (en) Organic compounds
MX2010002246A (es) Nuevos herbicidas.
NO20071100L (no) 5-jodtetrazoler
DE602005007064D1 (de) Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
TW200745090A (en) Chemical compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1869032

Country of ref document: EP

REN Ceased due to non-payment of the annual fee